Efficiently manage enzyme assays and measuring conditions for consistent and reliable performance
To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Efficiently manage enzyme assays and measuring conditions for consistent and reliable performance
Precise temperature control and accurate incubation time in seconds eliminates manual errors ✓ Up to 350 tests per hour for a true walk-away solution, fully traceable and audit trailed ✓ Many enzymes, many substratesm many methods – all on a single instrument ✓ more
SureSTART autosampler vials for all chromatography applications and budgets
Sample security and low compound adsorption to keep your samples safe and secure ✓ Three distinct performance levels to meet your price and performance needs ✓ Complete instrument compatibility for all chromatography autosamplers ✓ more
Next-generation cleanroom confidence for cell therapy research and manufacturing
Active particle control system – Certified compatible with ISO Class 5 and GMP Grade A/B ✓ High performance – Active airflow technology, in-chamber HEPA filtration and high heat sterilization ✓ Enhanced cleaning compatibility - IP54 compliant and STERIS compatible ✓ more
LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, announced a total of $22.4 million in sponsorship commitments for LabCentral 238, a fully functional life sciences laboratory with a focus on scale-up bio-manufacturing. Th ... more
Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement
Thermo Fisher Scientific Inc. and QIAGEN N.V. announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN. The amendment provides for an increase from the original of ... more
Thermo Fisher Scientific to Acquire QIAGEN
Thermo Fisher Scientific Inc. and QIAGEN N.V. announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher’s proposal to acquire QIAGEN for €39 per share in cash. The offer price represents a premium of approximately 23% to ... more
Learn how breath analysis can detect disease and cancer in its early stage
Breath Biopsy offers a non-invasive and pain free way to monitor human biology and enable the critical early detection of disease more
Clinical research and forensic handbook
Comprehensive collection of information for clinical/translational/drug monitoring research, forensic testing, and sports antidoping analysis more
Delivering on the Promise of the Paperless Lab
Organizations have made significant investments in enterprise and laboratory tools, technologies and solutions to help improve productivity, better manage data/information and optimize their business processes. However, the reality is that most comp more
Thermo Fisher Scientific is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research ... more